Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

Novo Nordisk A/S3,618 enrolled

Overview

This study is conducted in Europe. The aim of this study is to investigate psychosocial factors related to compliance with treatment with biphasic insulin analogues.

Study Type

OBSERVATIONAL

Enrollment

3,618

Conditions

Diabetes Diabetes Mellitus, Type 2

Interventions

No treatment givenOTHER

Patients to complete the "WHO-5 Well-being Index" questionnaire

No treatment givenOTHER

Physicians to complete two questionnaires, "Demographic Data and Disease and Treatment Course" and "Questionnaire of Potential Difficulties in the Period of Treatment Switching from Insulin to Its Analogues"

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with type 2 diabetes in whom therapy with biphasic insulin analogues was started

Locations (1)

Novo Nordisk Investigational Site

Warsaw, Poland

Outcomes

Primary Outcomes

Frequency and level of difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins

Time frame: Up to 3 months

Secondary Outcomes

Correlations between the difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins, and psychosocial factors

Time frame: Up to 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.